More Breast Cancer Patients Opt for Mastectomy Than Previously

by U.S. Medicine

March 9, 2015

NASHVILLE – Many more breast cancer patients now opt for mastectomy, including removal of both breasts, instead of choosing breast conservation surgery (BCS), even with early-stage disease confined to one breast, according to a new study.

The rates of increase were steepest among women with lymph node-negative and in situ disease, according to Vanderbilt University researchers, who noted the reversal of trends seen since the 1990s, when BCS was found to produce equivalent cancer outcomes and was endorsed as a standard of excellence by a National Institutes of Health Consensus Conference.

The study, published online recently by JAMA Surgery, was funded by the VA and used facilities of the VA Tennessee Valley Healthcare System in Nashville.1

For the study, researchers used the National Cancer Data Base to study records of more than 1.2 million adult women treated at centers accredited by the American Cancer Society and the American College of Surgeons Commission on Cancer from Jan. 1, 1998, to Dec. 31, 2011.

In that time period, 35.5% of those women underwent mastectomy, with the adjusted odds of mastectomy in BCS-eligible women increasing 34% during the most recent eight years of the study period. Rates of bilateral mastectomy as a result of cancer in one breast increased from 1.9% to 11.2% from 1998 to 2011.

In women undergoing mastectomy, rates of breast reconstruction increased from 11.6% to 36.4% in the same time period.

Mastectomy rate increases in the U.S. were especially common in younger women with noninvasive disease, those with smaller tumors and those with node-negative disease, indicating the cancer was less likely to spread beyond the initial tumor, according to the study.

The authors suggest that several trends might be influencing patient decision-making, including that the National Accreditation Program for Breast Centers expects that all women undergoing mastectomy be offered reconstruction. The Women’s Health and Cancer Rights Act, passed in 1998, mandates insurance coverage of post-mastectomy reconstruction. Earlier research found that the law significantly increased the proportion of women insured by Medicare and Medicaid who underwent reconstructive procedures.

“Our findings of still-increasing rates of mastectomy, breast reconstruction and bilateral mastectomy in women with early-stage breast cancer has implications for physician and patient decision-making, as well as quality measurement,” said lead author Kristy Kummerow, MD.

The study could not determine the number of patients who have tested positive for mutations in the BRCA gene which greatly increases the risk of developing breast cancer, and may influence women to remove both breasts. The research also could not determine the number of patients whose tumors have been identified as triple-negative; those hormone receptor negative tumors are more aggressive and difficult to treat.

1 Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide Trends in Mastectomy for Early-Stage Breast Cancer. JAMA Surg. 2014 Nov 19. doi: 10.1001/jamasurg.2014.2895. [Epub ahead of print] PubMed PMID: 25408966. 


Comments are closed here.


Related Articles

Effective Metrics Help VA Exceed National Goal for Colorectal Cancer Screening

More Than 80% of Patients Meet Recommendations LOS ANGELES—More than four out of five veterans eligible for colorectal cancer screening have been screened, putting the largest healthcare system in the United States among the top... View Article

More Options, Better Survival for Veterans With Metastatic Pancreatic Cancer

ALBANY, NY—Pancreatic cancer remains one of the deadliest malignancies in the United States, but new therapies can extend life and improve quality of life for many patients. That is especially the case at the VA,... View Article


U.S. Medicine Recommends


More From oncology

Oncology

Effective Metrics Help VA Exceed National Goal for Colorectal Cancer Screening

More Than 80% of Patients Meet Recommendations LOS ANGELES—More than four out of five veterans eligible for colorectal cancer screening have been screened, putting the largest healthcare system in the United States among the top... View Article

Oncology

More Options, Better Survival for Veterans With Metastatic Pancreatic Cancer

ALBANY, NY—Pancreatic cancer remains one of the deadliest malignancies in the United States, but new therapies can extend life and improve quality of life for many patients. That is especially the case at the VA,... View Article

Oncology

Military Risks for Ocular Surface Squamous Neoplasia

MIAMI—While a variety of risk factors have been evaluated in ocular surface squamous neoplasia, few studies have assessed risk factors specific to the armed forces veteran population. A report in the journal Eye and Vision... View Article

Oncology

Antibiotics Appear to Inhibit Tumor Activity in CTCL

AARHUS, DENMARK—Do CD4 T cell responses to  Staphylococcus aureus inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T cell lymphoma? A prospective study in the journal Blood examined that question, exploring the... View Article

Oncology

Lower Dose Cisplatin Preferable in Squamous Cell Carcinoma

PHILADELPHIA—Chemoradiotherapy is commonly used for nonoperative treatment of locally advanced head and neck squamous cell carcinoma. The issue, according to a recent study, is that the standard dose of 100 mg/m2 cisplatin every three weeks is... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up